Advanced breast cancer patients can benefit from immunotherapy-chemotherapy combinati

[News]

Patients with an aggressive form of advanced breast cancer can benefit from immunotherapy when used in combination with chemotherapy as first-line treatment, according to the results of a large international Phase III clinical trial published today in the New England Journal of Medicine and led by a researcher at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine.

More... (https://www.news-medical.net/news/20181023/Advanced-breast-cancer-patients-can-benefit-from-immunotherapy-chemotherapy-combination.aspx)